The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 178, 7520 -7524
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, C. M.
Right arrow Articles by Tapping, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, C. M.
Right arrow Articles by Tapping, R. I.

Cutting Edge: A Common Polymorphism Impairs Cell Surface Trafficking and Functional Responses of TLR1 but Protects against Leprosy1

Christopher M. Johnson*,§, Elizabeth A. Lyle*, Katherine O. Omueti{dagger},§, Vitaly A. Stepensky{ddagger},§, Olcay Yegin, Erkan Alpsoy||, Lutz Hamann#, Ralf R. Schumann# and Richard I. Tapping2,*,§

* Department of Microbiology, {dagger} Department of Biochemistry, {ddagger} Department of Cell and Developmental Biology, and § College of Medicine, University of Illinois, Urbana, IL 61801; Department of Pediatric Immunology and || Department of Dermatology and Venerology, Akdeniz University School of Medicine, Akdeniz University, Antalya, Turkey; and # Institute of Microbiology and Hygiene, Charité-University Medical Center, Humboldt-University Berlin, Berlin, Germany

TLRs constitute an essential family of pattern recognition molecules that, through direct recognition of conserved microbial components, initiate inflammatory responses following infection. In this role, TLR1 enables host responses to a variety of bacteria, including pathogenic species of mycobacteria. In this study, we report that I602S, a common single nucleotide polymorphism within TLR1, is associated with aberrant trafficking of the receptor to the cell surface and diminished responses of blood monocytes to bacterial agonists. When expressed in heterologous systems, the TLR1 602S variant, but not the TLR1 602I variant, exhibits the expected deficiencies in trafficking and responsiveness. Among white Europeans, the 602S allele represents the most common single nucleotide polymorphism affecting TLR function identified to date. Surprisingly, the 602S allele is associated with a decreased incidence of leprosy, suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Deutsche Forschungsgemeinschaft (to R.S.) and the National Institutes of Health, National Institute of Allergy and Infectious Diseases Grant AI052344 (to R.I.T.). Crude membrane fraction from Mycobacterium tuberculosis was obtained from Colorado State University under National Institute of Allergy and Infectious Diseases contract N01 AI75320.

2 Address correspondence and reprint requests to Dr. Richard I. Tapping, Department of Microbiology, University of Illinois, B103 CLSL MC110, 601 South Goodwin Avenue, Urbana, IL 61801. E-mail address: tapping{at}life.uiuc.edu

3 Abbreviation used in this paper: SNP, single nucleotide polymorphism.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Nagpal, T. S. Plantinga, J. Wong, B. G. Monks, N. J. Gay, M. G. Netea, K. A. Fitzgerald, and D. T. Golenbock
A TIR Domain Variant of MyD88 Adapter-like (Mal)/TIRAP Results in Loss of MyD88 Binding and Reduced TLR2/TLR4 Signaling
J. Biol. Chem., September 18, 2009; 284(38): 25742 - 25748.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. A. J. O'Neill, C. E. Bryant, and S. L. Doyle
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
Pharmacol. Rev., June 1, 2009; 61(2): 177 - 197.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. P. Purdue, Q. Lan, S. S. Wang, A. Kricker, I. Menashe, T.-Z. Zheng, P. Hartge, A. E. Grulich, Y. Zhang, L. M. Morton, et al.
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma
Carcinogenesis, February 1, 2009; 30(2): 275 - 281.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. M. Wurfel, A. C. Gordon, T. D. Holden, F. Radella, J. Strout, O. Kajikawa, J. T. Ruzinski, G. Rona, R. A. Black, S. Stratton, et al.
Toll-like Receptor 1 Polymorphisms Affect Innate Immune Responses and Outcomes in Sepsis
Am. J. Respir. Crit. Care Med., October 1, 2008; 178(7): 710 - 720.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. A. Sieling, P. J. Hill, K. M. Dobos, K. Brookman, A. M. Kuhlman, M. Fabri, S. R. Krutzik, T. H. Rea, D. G. Heaslip, J. T. Belisle, et al.
Conserved Mycobacterial Lipoglycoproteins Activate TLR2 but Also Require Glycosylation for MHC Class II-Restricted T Cell Activation
J. Immunol., May 1, 2008; 180(9): 5833 - 5842.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.